Nanologica AB (publ) (FRA:4YD)

Market Cap	6.92M -25.3%
Revenue (ttm)	1.95M +45.3%
Net Income	-4.74M
EPS	-0.05
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	50
Open	0.0474
Previous Close	0.0422
Day's Range	0.0474 - 0.0474
52-Week Range	0.0020 - 0.1475
Beta	n/a
RSI	56.24
Earnings Date	Apr 24, 2026

About Nanologica AB

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and pu...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2004
• Employees: 19
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4YD

Financial Performance

In 2025, Nanologica AB's revenue was 21.13 million, an increase of 45.32% compared to the previous year's 14.54 million. Losses were -51.29 million, -21.85% less than in 2024.

Financial numbers in SEK